Dr. Flora Peyvandi is Professor of Internal Medicine at the University of Milan and Director of the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center at Milan Policlinic Hospital, Italy. Her research focuses on coagulation disorders, microvascular dysfunction, and innovative diagnostic and therapeutic strategies. She has held leading roles in international scientific societies, including President of the International Society on Thrombosis and Haemostasis, and currently serves as an advisor to the European Medicines Agency and the Italian Ministry of Health.

Dr. Gerry Dolan is a consultant hematologist and hemophilia centre director at St Thomas’ Comprehensive Care Centre, London, UK, and former centre director at Nottingham University Hospitals, Nottingham, UK. He is former chairman of the UK Hemophilia Centre Directors and president of the British Society for Haemostasias & Thrombosis. He has been an active participant in collaborative European initiatives in hemophilia and has chaired initiatives such as the ADVANCE group and the European Hemophilia Therapy Standardization Board. His interests include novel agents in the treatment of hemophilia, gene therapy and clinical outcomes.

Dr. Flora Peyvandi is Professor of Internal Medicine at the University of Milan and Director of the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center at Milan Policlinic Hospital, Italy. Her research focuses on coagulation disorders, microvascular dysfunction, and innovative diagnostic and therapeutic strategies. She has held leading roles in international scientific societies, including President of the International Society on Thrombosis and Haemostasis, and currently serves as an advisor to the European Medicines Agency and the Italian Ministry of Health.